Phibro Animal Health Statistics
Total Valuation
PAHC has a market cap or net worth of $993.07 million. The enterprise value is $1.69 billion.
| Market Cap | 993.07M |
| Enterprise Value | 1.69B |
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | Jun 4, 2025 |
Share Statistics
PAHC has 40.53 million shares outstanding. The number of shares has increased by 0.33% in one year.
| Current Share Class | 20.37M |
| Shares Outstanding | 40.53M |
| Shares Change (YoY) | +0.33% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 50.12% |
| Owned by Institutions (%) | 52.04% |
| Float | 20.20M |
Valuation Ratios
The trailing PE ratio is 31.39 and the forward PE ratio is 11.44. PAHC's PEG ratio is 3.37.
| PE Ratio | 31.39 |
| Forward PE | 11.44 |
| PS Ratio | 0.83 |
| Forward PS | n/a |
| PB Ratio | 3.73 |
| P/TBV Ratio | 5.72 |
| P/FCF Ratio | 20.24 |
| P/OCF Ratio | 11.38 |
| PEG Ratio | 3.37 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.83, with an EV/FCF ratio of 34.41.
| EV / Earnings | 53.10 |
| EV / Sales | 1.42 |
| EV / EBITDA | 10.83 |
| EV / EBIT | 14.69 |
| EV / FCF | 34.41 |
Financial Position
The company has a current ratio of 2.91, with a Debt / Equity ratio of 2.89.
| Current Ratio | 2.91 |
| Quick Ratio | 1.02 |
| Debt / Equity | 2.89 |
| Debt / EBITDA | 4.59 |
| Debt / FCF | 15.70 |
| Interest Coverage | 3.57 |
Financial Efficiency
Return on equity (ROE) is 11.86% and return on invested capital (ROIC) is 7.85%.
| Return on Equity (ROE) | 11.86% |
| Return on Assets (ROA) | 6.26% |
| Return on Invested Capital (ROIC) | 7.85% |
| Return on Capital Employed (ROCE) | 10.94% |
| Revenue Per Employee | $613,754 |
| Profits Per Employee | $16,388 |
| Employee Count | 1,940 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 2.21 |
Taxes
In the past 12 months, PAHC has paid $18.76 million in taxes.
| Income Tax | 18.76M |
| Effective Tax Rate | 37.11% |
Stock Price Statistics
The stock price has increased by +39.60% in the last 52 weeks. The beta is 0.62, so PAHC's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +39.60% |
| 50-Day Moving Average | 20.37 |
| 200-Day Moving Average | 21.52 |
| Relative Strength Index (RSI) | 75.21 |
| Average Volume (20 Days) | 235,445 |
Short Selling Information
The latest short interest is 912,469, so 2.25% of the outstanding shares have been sold short.
| Short Interest | 912,469 |
| Short Previous Month | 872,692 |
| Short % of Shares Out | 2.25% |
| Short % of Float | 4.52% |
| Short Ratio (days to cover) | 3.93 |
Income Statement
In the last 12 months, PAHC had revenue of $1.19 billion and earned $31.79 million in profits. Earnings per share was $0.78.
| Revenue | 1.19B |
| Gross Profit | 384.23M |
| Operating Income | 114.94M |
| Pretax Income | 25.95M |
| Net Income | 31.79M |
| EBITDA | 155.90M |
| EBIT | 114.94M |
| Earnings Per Share (EPS) | $0.78 |
Balance Sheet
The company has $75.05 million in cash and $770.02 million in debt, giving a net cash position of -$694.97 million or -$17.15 per share.
| Cash & Cash Equivalents | 75.05M |
| Total Debt | 770.02M |
| Net Cash | -694.97M |
| Net Cash Per Share | -$17.15 |
| Equity (Book Value) | 265.99M |
| Book Value Per Share | 6.56 |
| Working Capital | 509.54M |
Cash Flow
In the last 12 months, operating cash flow was $87.28 million and capital expenditures -$38.22 million, giving a free cash flow of $49.06 million.
| Operating Cash Flow | 87.28M |
| Capital Expenditures | -38.22M |
| Free Cash Flow | 49.06M |
| FCF Per Share | $1.21 |
Margins
Gross margin is 32.27%, with operating and profit margins of 9.65% and 2.67%.
| Gross Margin | 32.27% |
| Operating Margin | 9.65% |
| Pretax Margin | 4.25% |
| Profit Margin | 2.67% |
| EBITDA Margin | 13.09% |
| EBIT Margin | 9.65% |
| FCF Margin | 4.12% |
Dividends & Yields
This stock pays an annual dividend of $0.48, which amounts to a dividend yield of 1.96%.
| Dividend Per Share | $0.48 |
| Dividend Yield | 1.96% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 61.50% |
| Buyback Yield | -0.33% |
| Shareholder Yield | 1.63% |
| Earnings Yield | 3.20% |
| FCF Yield | 4.94% |
Analyst Forecast
The average price target for PAHC is $20.00, which is -18.37% lower than the current price. The consensus rating is "Sell".
| Price Target | $20.00 |
| Price Target Difference | -18.37% |
| Analyst Consensus | Sell |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 3.02% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PAHC has an Altman Z-Score of 2.4 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.4 |
| Piotroski F-Score | 6 |